A 34-year-old patient came in last month with three years of progressive frontal recession. He had tried finasteride for six months and stopped because of sexual side effects he found intolerable. He had read on a forum that saw palmetto was a natural alternative, had taken it for fourteen months, and was still losing hair. His scalp showed classic Norwood pattern III, his free testosterone was midrange, his thyroid was normal, and his ferritin was fine. He wanted to know what his actual options were that did not involve the medication that had affected him.
This is one of the most common conversations I have in the hair consult room. Finasteride works for many men. For a meaningful subset it produces sexual side effects, mood changes, or post-finasteride syndrome that justifies stopping. For women it is generally not used at all because of the teratogenic risk and the limited evidence base. The question of what actually works in place of finasteride deserves a straight answer rather than the supplement-aisle marketing most patients have already been through.
What finasteride is doing in the first place — so we know what we are replacing
Androgenetic alopecia in both men and women is driven primarily by the action of dihydrotestosterone (DHT) on genetically susceptible hair follicles. DHT binds to androgen receptors on follicle cells in the frontal scalp, vertex, and temples, and triggers a process called miniaturization — each successive growth cycle produces a thinner, shorter, less pigmented hair until the follicle eventually stops producing terminal hair entirely. The process is gradual but progressive without intervention.
Finasteride works by inhibiting the enzyme 5-alpha reductase, which converts testosterone to DHT. By lowering systemic DHT by 60 to 70 percent at the standard 1 mg daily dose, finasteride slows or stops miniaturization in most men, and in some men produces measurable regrowth. The mechanism is well-understood and the efficacy data is robust. The problem is the side-effect profile in the subset of patients who are sensitive to it.
Anything that is going to "replace" finasteride for androgenetic alopecia has to either reduce DHT effect at the follicle through a different mechanism, work around the DHT pathway entirely by stimulating regrowth through other signaling, or address contributing factors that are amplifying the genetic susceptibility. Most of the supplements marketed as natural alternatives do none of these effectively at the doses sold.
What I look for in the workup before recommending anything
Before I tell a patient what to do, I want to know what is actually driving their hair loss, because androgenetic alopecia is the most common cause but it is not the only cause, and treating it as if it were when it is not produces poor outcomes.
The history I take covers timing of onset (gradual versus sudden), pattern (frontal and vertex versus diffuse versus patchy), family pattern, recent stressors or illnesses, postpartum status in women, recent weight changes, dietary changes including aggressive caloric restriction or low-protein diets, medication changes (statins, retinoids, anticoagulants, lithium, valproic acid, certain beta-blockers, and oral contraceptive changes are all common drivers), and any scalp symptoms — itching, burning, scaling — that suggest an inflammatory process.
The exam covers pattern of loss, scarring versus non-scarring, follicle density, hair shaft characteristics, and a pull test to look for active shedding. Trichoscopy when relevant.
The labs typically include CBC, ferritin (a single most useful number — I want it above 70 ng/mL for active hair growth), TSH with free T3 and free T4, vitamin D, zinc when clinically indicated, and a hormone panel that includes total and free testosterone, SHBG, DHEA-S, and (in women with hyperandrogenic features) consideration of further androgen workup.
What I look for: nutritional contributors that are correctable, hormonal contributors that explain the pattern, inflammatory or scarring features that change the diagnostic category entirely, and the underlying androgenetic pattern that is the actual primary mechanism in most male-pattern and female-pattern cases.
What actually works in place of finasteride
For patients who cannot or will not take finasteride, the realistic alternatives that have meaningful evidence behind them are limited but real.
Topical minoxidil remains a foundational option. It does not work on the DHT pathway at all — it works through vasodilation, prolongation of the anagen growth phase, and mechanisms that are still being characterized. Five percent solution or foam used twice daily produces meaningful response in roughly 40 to 60 percent of users for stopping progression, and a smaller percentage for visible regrowth. It is well-tolerated for most patients. The two real downsides are the maintenance commitment (stopping causes loss of any gains over six to twelve months) and a transient initial shed in the first two to eight weeks that some patients find alarming.
Topical minoxidil with topical finasteride is an option for patients whose concern with finasteride is systemic side effects rather than the molecule itself. Topical finasteride at appropriate concentrations achieves significant scalp DHT reduction with substantially lower serum DHT effect than oral, and tolerability data is reasonable. This is a compounded preparation rather than something you pick up at a pharmacy.
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
Oral minoxidil at low doses (typically 1.25 to 2.5 mg) has emerged in the dermatology literature over the past several years as an effective option for both male- and female-pattern hair loss, with a reasonable safety profile in selected patients. It requires monitoring for hypotension, edema, and unwanted facial or body hair growth. It is a real option in patients who cannot tolerate topical minoxidil or who want a more convenient alternative.
Regenerative scalp work — what we provide as DE|RIVE hair restoration — is the option that does not work through the DHT pathway at all. The protocol combines scalp microneedling at a controlled depth with EXO|E exosome therapy. The microneedling triggers a wound-healing response that activates dormant follicles and recruits growth factors locally. The exosomes deliver concentrated growth factor signaling — including signals that drive follicles back into the active growth phase — directly to the treatment field. The mechanism is genuine, the evidence base is growing, and in my practice the response in carefully selected patients is meaningful.
Vampire facial PRP protocols adapted for the scalp use the patient's own platelets to deliver growth factors. The mechanism overlaps with what exosomes do, with somewhat different signaling. PRP is a reasonable option, particularly for patients who prefer an autologous product.
Saw palmetto, pumpkin seed oil, and the rest of the supplement aisle have weak evidence at best. Saw palmetto has a small effect on DHT in some studies, but the magnitude is well below finasteride and the clinical hair response in head-to-head comparisons is modest. I will not tell a patient not to take them, but I will tell them not to expect them to be the answer.
How I evaluate the right combination for a specific patient
The plan I build depends on the specific picture. For a young man with classic male-pattern loss, an intolerance to oral finasteride, and motivated commitment to a maintenance program, I will often combine topical minoxidil daily with a series of regenerative scalp treatments — typically four sessions at four-to-six-week intervals, then maintenance every four to six months. Topical finasteride may be added if minoxidil alone is insufficient. Adjacent factors get addressed too — ferritin to above 70, vitamin D to above 40, sleep optimization, dietary protein adequacy.
For a woman with female-pattern hair loss, the conversation includes a hormonal evaluation that often points toward the perimenopausal transition or postpartum recovery. The plan combines hormone therapy where indicated with topical or low-dose oral minoxidil and regenerative scalp treatment. The hormonal piece is foundational — addressing the substrate the regenerative treatment depends on — and trying to grow hair on suboptimal hormone status is a losing battle in midlife women.
For a man whose hair loss is happening in the context of low testosterone with elevated SHBG and low free testosterone, men's hormone therapy gets discussed carefully. Testosterone optimization can convert to DHT and theoretically worsen androgenetic alopecia, but the relationship is not linear and the clinical response varies. Scalp-directed treatment in parallel with thoughtful systemic management is usually the right call rather than withholding indicated hormone therapy out of theoretical concern.
For patients whose workup identifies telogen effluvium rather than androgenetic alopecia, the answer is removing the trigger and supporting recovery — usually nutritional repletion, stress and sleep work, and time. Regenerative treatment can accelerate the recovery but is not strictly necessary.
For patients whose workup identifies a cicatricial alopecia, no regenerative scalp work is appropriate until the underlying inflammatory process is controlled, usually through dermatology referral.
The timeline patients should expect
Hair grows slowly. The active growth phase of a single hair lasts years. Any treatment that affects hair growth is going to take months to show, because the follicle has to complete a cycle and start a new one before the result is visible above the scalp.
Realistic expectations: shedding reduction at eight to twelve weeks if shedding was a primary symptom; visible improvement in density at four to six months; full evaluation of treatment response at nine to twelve months. Photographic tracking at consistent angles and lighting is part of the protocol because the daily mirror does not show the gradual change well. Patients who commit to the timeline and the maintenance schedule do well. Patients who expect dramatic change at six weeks generally stop too early.
What to do if this is your situation
If you have been on finasteride and stopped, are considering hair restoration without it, or have spent a year cycling through supplements without getting answers, the starting point is a real evaluation. Book a scalp consultation at either the Columbus or Warner Robins clinic — pick the location convenient to you, the protocols are identical at both. Bring any prior labs, a complete medication and supplement list, and front and side photos of your scalp from a few months ago if you have them.
We will run the appropriate workup, identify what is actually driving your hair loss, and build a plan that fits your specific picture. If finasteride genuinely is not an option for you, there are real alternatives — but they need to be matched to your mechanism, and they need a plan that gives them the time they need to work.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.

